Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 2009, p. 1892-1897, Vol. 53, No. 5
0066-4804/09/$08.00+0 doi:10.1128/AAC.01400-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
New Plasmid-Mediated Quinolone Resistance Gene, qnrC, Found in a Clinical Isolate of Proteus mirabilis
Minghua Wang,1,
Qinglan Guo,1,
Xiaogang Xu,1
Xiaoying Wang,1
Xinyu Ye,1
Shi Wu,1
David C. Hooper,2 and
Minggui Wang1,3*
Institute of Antibiotics, Huashan Hospital,1
Institute of Biomedical Sciences, Fudan University, Shanghai 200040, China,3
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts2
Received 18 October 2008/
Returned for modification 10 January 2009/
Accepted 22 February 2009

ABSTRACT
Since the discovery of
qnrA in 1998, two additional
qnr genes,
qnrB and
qnrS, have been described. These three plasmid-mediated
genes contribute to quinolone resistance in gram-negative pathogens
worldwide. A clinical strain of
Proteus mirabilis was isolated
from an outpatient with a urinary tract infection and was susceptible
to most antimicrobials but resistant to ampicillin, sulfamethoxazole,
and trimethoprim. Plasmid pHS10, harbored by this strain, was
transferred to azide-resistant
Escherichia coli J53 by conjugation.
A transconjugant with pHS10 had low-level quinolone resistance
but was negative by PCR for the known
qnr genes,
aac(6')-Ib-cr and
qepA. The ciprofloxacin MIC for the clinical strain and
a J53/pHS10 transconjugant was 0.25 µg/ml, representing
an increase of 32-fold relative to that for the recipient, J53.
The plasmid was digested with HindIII, and a 4.4-kb DNA fragment
containing the new gene was cloned into pUC18 and transformed
into
E. coli TOP10. Sequencing showed that the responsible 666-bp
gene, designated
qnrC, encoded a 221-amino-acid protein, QnrC,
which shared 64%, 42%, 59%, and 43% amino acid identity with
QnrA1, QnrB1, QnrS1, and QnrD, respectively. Upstream of
qnrC there existed a new IS
3 family insertion sequence, IS
Pmi1, which
encoded a frameshifted transposase.
qnrC could not be detected
by PCR, however, in 2,020 strains of
Enterobacteriaceae. A new
quinolone resistance gene,
qnrC, was thus characterized from
plasmid pHS10 carried by a clinical isolate of
P.
mirabilis.

INTRODUCTION
Plasmid-mediated quinolone resistance was first described for
a ciprofloxacin-resistant strain of
Klebsiella pneumoniae in
1998 (
15). The responsible gene,
qnr (later named
qnrA), was
located on plasmid pMG252, which encodes multidrug resistance
proteins.
qnrB and
qnrS were discovered in 2005 and 2006, respectively,
and mediated similar levels of ciprofloxacin resistance (
9,
11). Qnr proteins belong to the pentapeptide repeat protein
(PRP) family and protect DNA gyrase and topoisomerase IV from
quinolone inhibition (
26,
27,
28).
qnr genes show a high level
of diversity; there are at least 6
qnrA, 20
qnrB, and 3
qnrS alleles reported, with one or more amino acid alterations within
each family (
12;
http://www.lahey.org/qnrStudies). More recently,
qnrD was found in
Salmonella isolates (
3).
qnr genes are widely
distributed in clinical
Enterobacteriaceae isolates around the
world and are usually associated with mobile elements (
21).
There were also
qnr-like genes found on the chromosomes of
Vibrio vulnificus,
Vibrio parahaemolyticus,
Photobacterium profundum,
Stenotrophomonas maltophilia, and gram-positive genera such
as
Enterococcus,
Listeria,
Clostridium, and
Bacillus (
1,
17,
22,
24). The wide distribution of
qnr genes in different species
of
Enterobacteriaceae and their high degree of diversity raise
the concern that there might be more
qnr genes that have not
yet been discovered. In this study, a new plasmid-mediated quinolone
resistance gene,
qnrC, was found on and cloned from a transferable
plasmid, pHS10, in a clinical isolate of
Proteus mirabilis.
The
qnrC gene, however, is rare and was not detected by PCR
in 2,020 strains of
Enterobacteriaceae isolated from Shanghai.

MATERIALS AND METHODS
Strains and plasmids.
Proteus mirabilis 06-489 was isolated from a urine specimen
of an outpatient with a urinary tract infection in 2006 in Huashan
Hospital, a teaching hospital of Fudan University in Shanghai.
Escherichia coli J53 Azi
r (resistant to azide) was used as the
recipient strain in conjugation experiments. Plasmids pUC18
(Amp
r [resistance to ampicillin]) and pHSG398 (Chl
r [resistance
to chloramphenicol]) (Takara Bio, Otsu, Japan) were used as
cloning vectors.
E. coli TOP10 (Invitrogen) was used for cloning.
Cultures were routinely grown in Luria-Bertani broth. Culture
plates contained tryptic soy agar (TSA) or Mueller-Hinton agar
(Oxoid, Basingstoke, England). Selective media contained sodium
azide (200 µg/ml) together with either ampicillin (100
µg/ml), ciprofloxacin (0.06 µg/ml), or sulfamethoxazole
(300 µg/ml).
A total of 2,020 nonduplicate clinical isolates of Enterobacteriaceae, regardless of their susceptibilities to antimicrobials, were collected from Huashan Hospital between 2005 and 2007, including 496 strains of K. pneumoniae, 63 strains of Klebsiella oxytoca, 492 strains of E. coli, 204 strains of Enterobacter spp. (186 strains of Enterobacter cloacae and 18 strains of Enterobacter aerogenes), 259 strains of P. mirabilis, 34 strains of Proteus vulgaris, 203 strains of Serratia marcescens, 137 strains of Morganella morganii, 63 strains of Citrobacter spp., 33 strains of Providencia spp., and 36 strains of other Enterobacteriaceae.
Cloning and nucleotide sequence analysis.
Plasmid DNA was isolated from an E. coli J53 derivative containing plasmid pHS10 by use of a Plasmid Midi kit (Qiagen GmbH, Hilden, Germany) and then ligated, after digestion with EcoRI or HindIII, into pUC18. The recombinants were transformed into E. coli TOP10, with selection on TSA plates containing ampicillin and ciprofloxacin. A clone carrying a plasmid with an approximately 4.4-kb HindIII insert, designated pHS11, was isolated, and the nucleotide sequence of the 4,409-bp insert was determined. A PCR fragment of 904 bp, which was internal to the HindIII fragment and encompassed the entire transcription unit of the PRP gene, was amplified with pHS10 as the template, using primers qnrCBam and qnrCSal (Table 1). The PCR product was digested with BamHI and SalI, cloned into pHSG398, and transformed into E. coli TOP10. The resultant construct, plasmid pHS12, was isolated, and its nucleotide sequence was verified. A gene encoding the PRP carried by pHS12 was designated qnrC.
Determination of qnrC start codon.
The putative translation initiation codons ATG, TTG, and ATT
of
qnrC were mutated using a QuikChange site-directed mutagenesis
kit (Stratagene, La Jolla, CA) to identify the start codon (Fig.
1). Mutagenesis was carried out on the pHS12 plasmid following
the experimental protocol of the manufacturer, and the transformant
was selected with chloramphenicol. Complementary forward and
reverse primers were designed to alter the DNA sequence from
5'ATG to 5'ACG, from 5'TTG to 5'ATG, 5'TTA, and 5'TCG, and from
5'ATT to 5'ATG and 5'TTA (Table
1). The resultant plasmid constructs
were called pHS12-ATGtoACG, pHS12-TTGtoATG, pHS12-TTGtoTTA,
pHS12-TTGtoTCG, pHS12-ATTtoATG, and pHS12-ATTtoTTA, respectively.
Susceptibility testing.
MICs were determined by the CLSI agar dilution methodology and
interpreted according to CLSI guidelines (
7). The Etest (Biodisk
AB, Solna, Sweden) was used to detect minimal changes in nalidixic
acid, ciprofloxacin, and levofloxacin susceptibilities for
P. mirabilis 06-489 and
E. coli strains containing pHS10 and recombinant
plasmids.
E. coli ATCC 25922 was used as a quality control strain
in susceptibility testing experiments.
Screening for qnrC in clinical strains.
PCR was used to investigate the prevalence of qnrC in 2,020 clinical strains, using primers qnrC-F and qnrC-R (Table 1). PCR conditions were 94°C for 30 s, 50°C for 30 s, and 72°C for 30 s for 30 cycles. Amplification products were detected by electrophoresis on a 1% agarose gel with ethidium bromide and were photographed under UV light. P. mirabilis 06-489 was used as a positive control and generated a 447-bp PCR product.
Nucleotide sequence accession number.
The nucleotide sequence in plasmid pHS10 containing qnrC has been submitted to GenBank and assigned accession number EU917444.

RESULTS
Cloning of qnrC.
A clinical strain of
P. mirabilis, strain 06-489, was susceptible
to quinolones and to cephalosporins, such as cefuroxime, cefotaxime,
and ceftazidime, but resistant to ampicillin, gentamicin, chloramphenicol,
tetracycline, sulfamethoxazole, and trimethoprim. Low-level
ciprofloxacin resistance could be transferred from
P. mirabilis 06-489 to
E. coli J53 Azi
r by conjugation. The plasmid responsible
was termed pHS10. The ciprofloxacin MIC for the clinical strain
and a J53/pHS10 transconjugant was 0.25 µg/ml, an increase
of 32-fold relative to that for J53 (Table
2). pHS10 was about
120 kb in size and was negative for known plasmid-mediated quinolone
resistance determinants, i.e.,
qnrA,
qnrB,
qnrS,
aac(6')-Ib-cr,
and
qepA, by PCR amplification. A 4,409-bp HindIII DNA fragment
and a 904-bp PCR product were cloned into pUC18 and pHSG398,
respectively, to obtain pHS11 and pHS12.
E. coli TOP10 cells
containing pHS11 and pHS12 had the same MICs for ciprofloxacin
(0.125 µg/ml) and levofloxacin (0.19 µg/ml) (Table
3). The DNA sequence of the 4,409-bp HindIII DNA insert was
determined with recombinant plasmid pHS11. Four open reading
frames (ORFs) were found by ORF Finder (
http://www.ncbi.nlm.nih.gov/projects/gorf/).
The ORFs showed that there was a conserved domain belonging
to the PRP family, with relatively high identities (>40%)
with
qnrA,
qnrB, and
qnrS, so we considered this a
qnr-like
gene. Three putative start codons were found in the ORF: peptide
synthesis of 178, 221, or 228 amino acids (aa) may start from
ATG, TTG, or ATT, respectively (Fig.
1).
View this table:
[in this window]
[in a new window]
|
TABLE 2. Susceptibilities of P. mirabilis 06-489 and E. coli transconjugant to three quinolones and other antimicrobialsa
|
View this table:
[in this window]
[in a new window]
|
TABLE 3. Susceptibilities of E. coli TOP10 cells harboring pHS12 derivatives to nalidixic acid, ciprofloxacin, and levofloxacin
|
Determination of start codon of qnrC.
The 178-aa PRP protein expressed starting at ATG of
qnrC was
40 or 48 amino acids shorter than QnrA1, QnrB1, and QnrS1. When
ATG was changed to ACG, a noninitiation codon, the MICs of
E. coli TOP10 harboring pHS12-ATGtoACG for ciprofloxacin and levofloxacin
were similar to those with pHS12 (Table
3), indicating that
the translation of mRNA still occurred and the function of the
QnrC protein was not affected by the mutation. Thus, this ATG
was not the start codon of
qnrC.
A 221-aa protein translated starting at TTG of qnrC had substantial similarity to QnrA1 (64%), QnrB1 (42%), and QnrS1 (59%) (Fig. 2). When TTG was mutated to ATG, the MICs of E. coli TOP10 harboring pHS12-TTGtoATG for ciprofloxacin and levofloxacin were similar to those with pHS12. When TTG was replaced with TCG or TTA, which are not start codons, the ciprofloxacin MIC for E. coli TOP10 harboring pHS12-TTGtoTCG or pHS12-TTGtoTTA decreased from 0.125 µg/ml to 0.003 or 0.006 µg/ml (Table 3). Furthermore, a predicted Shine-Dalgarno sequence (AAGAGG) was found to be located eight nucleotides upstream of the TTG initiation codon, an optimum distance for initiation of translation.
Another possible start codon, ATT, 21 bp upstream of TTG in
qnrC, was mutated to ATG or the non-start-codon TTA. The MICs
of
E. coli TOP10 harboring pHS12-ATTtoATG or pHS12-ATTtoTTA
for ciprofloxacin and levofloxacin were similar to those with
pHS12 (Table
3), indicating that ATT was also not a start codon
in
qnrC.
Therefore, TTG appeared to be the start codon of qnrC, which was 666 bp in length and encoded a 221-aa PRP.
Identity of QnrC with QnrA1, QnrB1, QnrS1, and other PRPs.
qnrC had 60%, 45%, 59%, and 32% nucleotide identity with qnrA1, qnrB1, qnrS1, and qnrD, respectively, while QnrC shared 64%, 42%, 59%, and 43% amino acid identity with QnrA1, QnrB1, QnrS1, and QnrD, respectively, by Clustal W alignment (http://align.genome.jp/) (Fig. 3).
qnrC had 58 to 68% identities with DNA sequences found in the
chromosome or plasmid in
Vibrio cholerae,
P. profundum,
Vibrio fischeri, and
Vibrio vulnificus (GenBank accession no. EU436855,
CR378678, CP000020, and AE016796, respectively), while QnrC
shared 59 to 70% amino acid identities with the PRPs found in
the above strains (ACC54440, CAG22829, AAW85819, and AAO07889,
respectively) (Fig.
4).
Genetic environment of qnrC.
There were four ORFs found in the 4.4-kb HindIII DNA fragment
containing
qnrC (Fig.
5).
qnrC was found downstream from
orfA and
orfB, which contained a new insertion sequence belonging
to the IS
51 group of the IS
3 family.
orfA and
orfB were partially
overlapping and arranged in reading phases 0 and –1, respectively.
The coding potential of
orfA was 107 aa and that of
orfB was
318 aa, and the putative OrfAB protein was 405 aa long. OrfAB
was a fusion protein with an identity of 58% to IS
51 (M14365),
which has transposase activity produced by the –1 programmed
ribosomal frameshift (PRF-1) (
4). A predicted –1 translational
frameshift signal (TTTTG) associated with an apical loop-internal
loop pseudoknot was deduced near the 3' end of
orfA and the
5' end of
orfB, suggesting the existence of frameshifted products
that could be responsible for transposition of this new IS element
(
5,
16).
The new insertion sequence has been designated IS
Pmi1 according
to guidelines for IS nomenclature for different bacterial species
(
http://www-is.biotoul.fr/). IS
Pmi1 is 1,306 bp in length and
has a pair of 26-bp imperfect inverted repeats at its termini,
with a conserved 5'-TG—-CA-3' sequence. A 3-bp direct
repeat (ATA) flanks the element, possibly as the result of a
transposition event. In IS
Pmi1, a putative Shine-Dalgarno sequence
was found upstream from the initiation codon of
orfA, but no
such sequence was present in the upstream region of
orfB.
Downstream from qnrC was orfD, which encoded a protein with highest identity (42%) to an amidase family protein from Methylococcus capsulatus (YP113430) (Fig. 5).
Effect of QnrC on quinolone susceptibility.
Like QnrA, QnrB, and QnrS, QnrC provided low-level resistance to quinolones, with a ciprofloxacin MIC of 0.25 µg/ml, in E. coli J53 (Table 2).
Prevalence of qnrC.
Unexpectedly, no qnrC PCR products were detected by PCR amplification of DNAs from 2,020 clinical strains of Enterobacteriaceae.

DISCUSSION
In this study,
qnrC was discovered from a clinical strain of
P.
mirabilis.
qnrC is a new plasmid-borne
qnr gene, in addition
to three existing families,
qnrA,
qnrB, and
qnrS. The name
qnrC was designated according to the recently published
qnr numbering
proposal by Jacoby et al. (
12).
qnrC differs substantially from
existing families, with >30% (40 to 68%) differences in comparison
to
qnrA,
qnrB,
qnrS, and
qnrD and also >30% (36 to 58%) differences
in derived amino acid sequences. Like other Qnr determinants,
QnrC provides low-level quinolone resistance, with a ciprofloxacin
MIC of 0.25 µg/ml for
E. coli J53.
Like other Qnr proteins found in gram-negative species, QnrC has a consensus sequence of (A,C)(D,N)(L,F)XX and contains two domains, of 11 and 32 units each, connected by a single glycine (G56), which is not conserved in PRPs from the gram-positive species studied (Fig. 3) (22, 26). AUG is the initiation codon used most frequently in prokaryotic genes. However, there are other non-AUG initiation codons, such as GUG and UUG, with frequencies of 8% and 1% in E. coli, respectively. Protein synthesis is still thought to be initiated with methionine because these codons are all decoded by the initiator fMet-tRNAfMet and translated as formylmethionine (14). Previous studies showed that initiation at AUG in E. coli is more efficient than that at the non-AUG codons (25). QnrC was deduced to initiate at UUG, an uncommon start codon, but it conferred low-level ciprofloxacin resistance (MIC, 0.25 µg/ml) similar to that of QnrA1, QnrB1, and QnrS1 (9, 11, 15).
qnrA and sometimes qnrB are associated with ISCR1 (IS common region 1; previously also called orf513), which is embedded in class 1 integrons (10, 13, 29). Some qnrB alleles are linked to orf1005, which encodes another putative integrase (11). A novel qnrB19 allele is associated with an ISEcp1-like insertion element that is able to mobilize the qnrB19 gene (2). Although qnrS has not been found on an integron thus far, it has been linked to insertion sequences such as IS26, an IS2 homolog, or ISEcl2, a novel insertion element belonging to the IS3 family (6, 10, 19, 20). qnrC is associated with ISPmi1, a member of the IS3 family, as well.
Members of the IS3 family are spread widely in more than 40 bacterial species and are characterized by lengths of between 1,200 and 1,550 bp. This family is divided into five subgroups, IS3, IS51, IS150, IS2, and IS407, based on alignment of the various OrfB sequences (4). OrfB and OrfAB of ISPmi1 contain a highly conserved DDE motif, a catalytic site of IS3 transposase. The spacing between the second catalytic aspartic acid (D) and glutamic acid (E) is conserved (35 aa), and a lysine (K) is present 7 aa downstream of the glutamic acid.
As a characteristic of the IS3 family, PRF-1 is a nonconventional translation phenomenon induced by a stimulatory signal. It involves the backward slippage of the ribosome by one nucleotide at a given point on the message. ISPmi1 shares a common genetic organization with members of the IS51 group, in which a potential tetrameric frameshift motif is accompanied by an elaborate frameshift stimulator, the apical loop-internal loop pseudoknot. Conserved structural elements similar to those in IS3411 and IS629 have been demonstrated experimentally to be involved in the control of gene expression by translational frameshifting, and the OrfAB transposase is indeed synthesized via PRF-1 on the predicted motif (5, 16).
Although no other qnrC gene was detected among 2,020 clinical strains of Enterobacteriaceae, two homologs, named qnrVC1 and qnrVC2 (8), are found in GenBank from two strains of V. cholerae O1, isolated from Brazil and Vietnam, both with 67% nucleotide identity to qnrC. qnrVC1 was located in gene cassettes of a class 1 integron and downstream of aadA2 in the Brazil strain (GenBank accession no. EU436855). qnrVC2 (GenBank accession no. AB200915) was also located on an integron, in plasmid pVN84, in the Vietnam strain, upstream from repA, orf1, and intI and downstream from dhfr6. QnrVC1 (GenBank accession no. ACC54440) has a high amino acid identity of 70% with QnrC. qnrVC2 could not be translated into a Qnr protein, since it has three nucleotide insertions and one nucleotide deletion compared to functional qnr genes.
It has been shown that Shewanella algae and Vibrio splendidus are probably the progenitors of qnrA- and qnrS-like genes (1, 18). QnrB-like proteins were recently found in Stenotrophomonas maltophilia (23) and members of the Vibrionaceae family (17). The 4.4-kb HindIII DNA fragment in this study showed strong nucleotide homology with chromosomal or plasmid sequences in the Vibrionaceae family, indicating that waterborne Vibrionaceae organisms might be the source of QnrC. Notably, the –1 to 206 nucleotide sequence of ISPmi1 showed 69% identity to the Shewanella sp. genome (GenBank accession no. CP000469), qnrC showed high identities with genomic sequences found in waterborne Vibrionaceae, such as P. profundum, V. cholerae, V. fischeri, and V. vulnificus, and the 3' end of the fragment from nucleotides 3723 to 4409 showed over 80% identity with genomes of Vibrio harveyi (CP000790), several Shewanella spp., and P. profundum SS9. These findings suggest that qnrC might be acquired from a chromosomal source in the Vibrionaceae family by the ISPmi1 insertion sequence. Gene movement and exchange, augmented by transduction, transformation, and conjugation in aquatic environments, might have occurred in association with the increased use of antimicrobials in fish farming. Aquatic environments carrying resistant bacteria are not only reservoirs of clinical resistance genes but also media for the spread and evolution of resistance genes (30).

ACKNOWLEDGMENTS
This work was supported by grant 2005CB0523101 (to M.W.) from
the National Basic Research Program of China from the Ministry
of Science and Technology, China, by grant 30572229 (to M.W.)
from the National Natural Science Foundation of China, by grant
LJ06052 (to M.W.) from the Shanghai Municipal Health Bureau,
and by grant AI57576 (to D.C.H.) from the National Institutes
of Health, U.S. Public Health Service.

FOOTNOTES
* Corresponding author. Mailing address: Institute of Antibiotics, Huashan Hospital, Fudan University, 12 M. Wulumuqi Rd., Shanghai 200040, People's Republic of China. Phone: (86-21)-52888195. Fax: (86-21)-62488290. E-mail:
mgwang{at}fudan.edu.cn 
Published ahead of print on 2 March 2009. 
M.W. and Q.G. contributed equally to this work. 

REFERENCES
1 - Cattoir, V., L. Poirel, D. Mazel, C. J. Soussy, and P. Nordmann. 2007. Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob. Agents Chemother. 51:2650-2651.[Free Full Text]
2 - Cattoir, V., P. Nordmann, J. Silva-Sanchez, P. Espinal, and L. Poirel. 2008. ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli. Antimicrob. Agents Chemother. 52:2929-2932.[Abstract/Free Full Text]
3 - Cavaco, L. M., H. Hasman, S. Xia, and F. M. Aarestrup. 2009. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovars Kentucky and Bovismorbificans of human origin. Antimicrob. Agents Chemother. 53:603-608.[Abstract/Free Full Text]
4 - Chandler, M., and J. Mahillon. 2002. Insertion sequences revisited, p. 305-366. In N. L. Craig, R. Craigie, M. Gellert, and A. Lambowitz (ed.), Mobile DNA, vol. 2. ASM Press, Washington, DC.
5 - Chen, C. C., and S. T. Hu. 2006. Two frameshift products involved in the transposition of bacterial insertion sequence IS629. J. Biol. Chem. 281:21617-21628.[Abstract/Free Full Text]
6 - Chen, Y.-T., H.-Y. Shu, L.-H. Li, T.-L. Liao, K.-M. Wu, Y.-R. Shiau, J.-J. Yan, I.-J. Su, S.-F. Tsai, and T.-L. Lauderdale. 2006. Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-β-lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob. Agents Chemother. 50:3861-3866.[Abstract/Free Full Text]
7 - Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement M100-S17, vol. 27, no. 1. Clinical and Laboratory Standards Institute, Wayne, PA.
8 - Fonseca, E. L., F. S. Freitas, V. V. Vieira, and C. P. Vicente. 2008. New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg. Infect. Dis. 14:1129-1131.[CrossRef][Medline]
9 - Hata, M., M. Suzuki, M. Matsumoto, M. Takahashi, K. Sato, S. Ibe, and K. Sakae. 2005. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother. 49:801-803.[Abstract/Free Full Text]
10 - Hu, F., X. Xu, D. Zhu, and M. Wang. 2008. Coexistence of qnrB4 and qnrS1 in a clinical strain of Klebsiella pneumoniae. Acta Pharmacol. Sin. 29:320-324.[CrossRef][Medline]
11 - Jacoby, G. A., K. E. Walsh, D. M. Mills, V. J. Walker, H. Oh, A. Robicsek, and D. C. Hooper. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50:1178-1182.[Abstract/Free Full Text]
12 - Jacoby, G., V. Cattoir, D. Hooper, L. Martínez-Martínez, P. Nordmann, A. Pascual, L. Poirel, and M. Wang. 2008. qnr gene nomenclature. Antimicrob. Agents Chemother. 52:2297-2299.[Free Full Text]
13 - Lascols, C., I. Podglajen, C. Verdet, V. Gautier, L. Gutmann, C. J. Soussy, E. Collatz, and E. Cambau. 2008. A plasmid-borne Shewanella algae gene, qnrA3, and its possible transfer in vivo between Kluyvera ascorbata and Klebsiella pneumoniae. J. Bacteriol. 190:5217-5223.[Abstract/Free Full Text]
14 - Laursen, B. S., H. P. Sorensen, K. K. Mortensen, and H. U. Sperling-Petersen. 2005. Initiation of protein synthesis in bacteria. Microbiol. Mol. Biol. Rev. 69:101-123.[Abstract/Free Full Text]
15 - Martinez-Martinez, L., A. Pascual, and G. A. Jacoby. 1998. Quinolone resistance from a transferable plasmid. Lancet 351:797-799.[CrossRef][Medline]
16 - Mazauric, M. H., P. Licznar, M. F. Prére, I. Canal, and O. Fayet. 2008. Apical loop-internal loop RNA pseudoknots: a new type of stimulator of –1 translational frameshifting in bacteria. J. Biol. Chem. 283:20421-20432.[Abstract/Free Full Text]
17 - Poirel, L., A. Liard, J. M. Rodriguez-Martinez, and P. Nordmann. 2005. Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. Antimicrob. Agents Chemother. 56:1118-1121.
18 - Poirel, L., J. M. Rodriguez-Martinez, H. Mammeri, A. Liard, and P. Nordmann. 2005. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother. 49:3523-3525.[Abstract/Free Full Text]
19 - Poirel, L., T. V. Nguyen, A. Weintraub, C. Leviandier, and P. Nordmann. 2006. Plasmid-mediated quinolone resistance determinant qnrS in Enterobacter cloacae. Clin. Microbiol. Infect. 12:1021-1023.[CrossRef][Medline]
20 - Poirel, L., V. Cattoir, A. Soares, C.-J. Soussy, and P. Nordmann. 2007. Novel Ambler class A β-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1. Antimicrob. Agents Chemother. 51:631-637.[Abstract/Free Full Text]
21 - Robicsek, A., G. A. Jacoby, and D. C. Hooper. 2006. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6:629-640.[CrossRef][Medline]
22 - Rodríguez-Martínez, J. M., C. Velasco, A. Briales, I. García, M. C. Conejo, and A. Pascual. 2008. Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J. Antimicrob. Chemother. 61:1240-1243.[Abstract/Free Full Text]
23 - Sánchez, M. B., A. Hernández, J. M. Rodríguez-Martínez, L. Martínez-Martínez, and J. L. Martínez. 2008. Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol. 8:148-161.[CrossRef][Medline]
24 - Shimizu, K., K. Kikuchi, T. Sasaki, N. Takahashi, M. Ohtsuka, Y. Ono, and K. Hiramatsu. 2008. Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 52:3823-3825.[Abstract/Free Full Text]
25 - Sussman, J. K., E. L. Simons, and R. W. Simons. 1996. Escherichia coli translation initiation factor 3 discriminates the initiation codon in vivo. Mol. Microbiol. 21:347-360.[CrossRef][Medline]
26 - Tran, J. H., and G. A. Jacoby. 2002. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA 99:5638-5642.[Abstract/Free Full Text]
27 - Tran, J. H., G. A. Jacoby, and D. C. Hooper. 2005. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 49:118-125.[Abstract/Free Full Text]
28 - Tran, J. H., G. A. Jacoby, and D. C. Hooper. 2005. Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV. Antimicrob. Agents Chemother. 49:3050-3052.[Abstract/Free Full Text]
29 - Wang, M., J. H. Tran, G. A. Jacoby, Y. Zhang, F. Wang, and D. C. Hooper. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47:2242-2248.[Abstract/Free Full Text]
30 - Young, H. K. 1993. Antimicrobial resistance spread in aquatic environments. J. Antimicrob. Chemother. 31:627-635.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, May 2009, p. 1892-1897, Vol. 53, No. 5
0066-4804/09/$08.00+0 doi:10.1128/AAC.01400-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., Robicsek, A.
(2009). Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin. Microbiol. Rev.
22: 664-689
[Abstract]
[Full Text]
-
Chmelnitsky, I., Hermesh, O., Navon-Venezia, S., Strahilevitz, J., Carmeli, Y.
(2009). Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. J Antimicrob Chemother
64: 718-722
[Abstract]
[Full Text]
-
Pallecchi, L., Riccobono, E., Mantella, A., Bartalesi, F., Sennati, S., Gamboa, H., Gotuzzo, E., Bartoloni, A., Rossolini, G. M.
(2009). High Prevalence of qnr Genes in Commensal Enterobacteria from Healthy Children in Peru and Bolivia. Antimicrob. Agents Chemother.
53: 2632-2635
[Abstract]
[Full Text]